Single- and Multiple-Dose Pharmacokinetics of Sublingual Sufentanil NanoTab PCA System (Zalviso) in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 09 Oct 2015
At a glance
- Drugs Sufentanil (Primary)
- Indications Pain
- Focus Pharmacokinetics
- Sponsors AcelRx Pharmaceuticals
- 28 Feb 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Feb 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 23 Jan 2013 New trial record